Internal Medicine, Pulmonary Disease · Richmond, VA
NPI
1811976582
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
417 N 11th St
Richmond, VA, 23298
Phone (804) 828-2161
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
252 services
Medicare patients, 2024
78
Average age 71
Drug cost, 2024
$4.4M
988 prescriptions
Company payments, 2025
$2,479
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nauman A Chaudary was code 99215 (office e&m - established), 86 times for 50 patients. In total Nauman A Chaudary billed 252 services in 20 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 86 | 50 | $129.25 | $11K |
| 99291 Critical Care E&M | Facility | 60 | 16 | $160.32 | $9,619 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 22 | $12.62 | $328 |
By year: 2022 $35K for 305 services; 2023 $24K for 267 services; 2024 $28K for 252 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nauman A Chaudary prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 137 prescriptions and refills. In total Nauman A Chaudary wrote 988 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 137 | 138 | 14 | $3.6M |
| Azithromycin Generic | 87 | 103 | 23 | $837 |
| Montelukast Sodium Generic | 60 | 105 | 14 | $474 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 45 | 47 | 13 | $903 |
| Omeprazole Generic | 41 | 57 | Under 11 | $297 |
| Creon Lipase/Protease/Amylase | 37 | 45 | Under 11 | $228K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 35 | 45 | Under 11 | $21K |
| Prednisone Generic | 34 | 34 | 18 | $144 |
| Zenpep Lipase/Protease/Amylase | 30 | 30 | Under 11 | $102K |
| Ciprofloxacin Hcl Generic | 29 | 29 | 15 | $255 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 23 | 27 | Under 11 | $17K |
| Symbicort Budesonide/Formoterol Fumarate | 22 | 24 | Under 11 | $4,932 |
| Pertzye Lipase/Protease/Amylase | 19 | 19 | Under 11 | $70K |
| Spiriva Handihaler Tiotropium Bromide | 19 | 19 | Under 11 | $9,405 |
| Tiotropium Bromide Generic | 18 | 21 | Under 11 | $6,833 |
Brand drugs: 505 claims; generic drugs: 483 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nauman A Chaudary $2,479 ($2,479 in general payments such as food, travel and fees) from 5 companies. The largest payer was Baxter Healthcare with $2,350.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.